Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype (Q22251117)

7 February 2023

5

Anne M Griffiths

Anne M

Griffiths

1 reference

7 February 2023

7

A Hillary Steinhart

A Hillary

Steinhart

1 reference

7 February 2023

2

Joanne M Stempak

Joanne M

Stempak

1 reference

7 February 2023

1

Cynthia H Seow

Cynthia H

Seow

1 reference

7 February 2023

Wei Xu

3

Wei

Xu

1 reference

7 February 2023

Hui Lan

series ordinal

4

author given names

Hui

author last names

Lan

1 reference

7 February 2023

Gordon R Greenberg

series ordinal

6

author given names

Gordon R

author last names

Greenberg

1 reference

7 February 2023

Nir Dotan

series ordinal

8

author given names

Nir

author last names

Dotan

1 reference

The American Journal of Gastroenterology

7 February 2023

language of work or name

English

0 references

publication date

21 April 2009

0 references

published in

0 references

volume

104

0 references

issue

6

0 references

page(s)

1426-1434

0 references

cites work

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

1 reference

https://api.crossref.org/works/10.1038/AJG.2009.79

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/AJG.2009.79

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/AJG.2009.79

Unravelling the pathogenesis of inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Inflammatory bowel disease: cause and immunobiology

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

IBD serological panels: facts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Anti-glycan antibodies as biomarkers for diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.79

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.79

0 references